Advertisement
Canada markets close in 4 hours 22 minutes
  • S&P/TSX

    22,319.81
    +60.34 (+0.27%)
     
  • S&P 500

    5,193.45
    +12.71 (+0.25%)
     
  • DOW

    38,921.04
    +68.77 (+0.18%)
     
  • CAD/USD

    0.7296
    -0.0025 (-0.35%)
     
  • CRUDE OIL

    78.28
    -0.20 (-0.25%)
     
  • Bitcoin CAD

    87,293.70
    +400.39 (+0.46%)
     
  • CMC Crypto 200

    1,322.01
    -43.11 (-3.16%)
     
  • GOLD FUTURES

    2,324.10
    -7.10 (-0.30%)
     
  • RUSSELL 2000

    2,075.71
    +15.03 (+0.73%)
     
  • 10-Yr Bond

    4.4290
    -0.0600 (-1.34%)
     
  • NASDAQ

    16,376.82
    +27.58 (+0.17%)
     
  • VOLATILITY

    13.51
    +0.02 (+0.15%)
     
  • FTSE

    8,313.90
    +100.41 (+1.22%)
     
  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     
  • CAD/EUR

    0.6770
    -0.0022 (-0.32%)
     

This Could Boost Eli Lilly’s Revenue Growth in 2018

In September, the FDA approved Eli Lilly's (LLY) Verzenio-fulvestrant combination therapy for the treatment of women with hormone receptor-positive or HR+.